Prostate cancer is the most common cancer among men in the United States. In 2010, an estimated 217,730 men will be diagnosed with the disease, and 32,050 will die from prostate cancer.1 Despite a lack of consensus regarding optimal diagnosis and management strategies for prostate cancer, recent data suggest that prostate cancer mortality is decreasing, from 38.6 per 100,000 in 1990 to 25.5 per 100,000 in 2004.1 The current chapter provides an overview of the epidemiology of prostate cancer, current strategies for screening and diagnosis, and treatments for both localized and advanced disease.
KeywordsProstate Cancer Radical Prostatectomy Zoledronic Acid External Beam Radiation Therapy Prostate Biopsy
- 2.Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2004. Bethesda, MD: National Cancer Institute; 2007Google Scholar
- 14.de Koning HJ, Auvinen A, Berenguer Sanchez A, et al. Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer. 2002;97:237PubMedCrossRefGoogle Scholar
- 17.Prostate cancer early detection. Practice guidelines in oncology. NCC Network. 2007. Published online by NCCN. http://www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdf
- 25.American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 6th ed. Chicago, IL: American Joint Committee on Cancer; 2002Google Scholar
- 39.Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American urological association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007;177:540PubMedCrossRefGoogle Scholar